Elevance Health Inc.

Health insurance premiums are contractual and recurring across more than 40 million enrolled members, with group commercial plans renewing annually at high retention rates; Elevance's operating revenue grew in each fiscal year from FY2020 through FY2025, including through the FY2020 COVID economic shock. The deliberate 2026 repositioning of Medicare Advantage and Medicaid membership is a managed volume decision within a transparent guidance framework, not an erosion of the contractual renewal structure.

Health Benefits contributed approximately $167 billion of the company's $197.6 billion in FY2025 operating revenue, representing over 84% of the total, with Carelon services providing some diversification through pharmacy benefits and care management. The insurance segment's structural dominance limits product diversification even as Carelon revenues grew 33% in FY2025.

Elevance operates exclusively within the United States through Blue Cross Blue Shield licenses in 14 states and national commercial accounts, with no material international revenue through FY2025. Roughly 32% of operating revenue derives from federal Medicare and state Medicaid programs, concentrating the revenue base entirely within a single domestic regulatory environment.

Carelon Services revenue grew 58% to $28.3 billion in FY2025, demonstrating meaningful operating leverage in the services layer, while combined Carelon revenues grew 33% to $71.7 billion. The core Health Benefits segment operates with a high incremental cost structure tied to medical loss ratios (93.5% benefit expense ratio in Q4 2025), limiting enterprise-level operating leverage while insurance remains the majority of external revenue.

Group commercial health insurance premiums are mission-critical and contractually renewed annually, with employer group accounts representing the most defensible portion of the revenue base. Government program revenues (approximately 32% of FY2025 operating revenue) add recurring volume but are subject to CMS rate-setting and state Medicaid cycles, as illustrated by the -1.75% Medicaid operating margin guided for FY2026.